FDA NDC Directory
Recently listed NDCs
Finished products in the FDA NDC Directory with the newest marketing start dates — new brands and generics, and new strengths or packages of existing products.
A listing is not an approval
The date shown is the marketing start date the labeler reported. Many new listings are generics, repackaged or relabeled products, or new package sizes. The marketing category (NDA, ANDA, BLA) on each product page says under what authority it is marketed.
Newest first
831 listings in the last 90 days
| Product | Strength | Form · route | Labeler | Listed | Product NDC |
|---|---|---|---|---|---|
| Genglycospariglasgene brecaparvovec-opnr | — | Kit | Ultragenyx Pharmaceutical Inc. | Sep 17, 2026 | 69794-345 |
| ziprasidone mesylate | Ziprasidone mesylate 20 mg/mL | Injection, Powder, Lyophilized, For solutionIntramuscular | REMEDYREPACK INC. | Sep 17, 2026 | 70518-4755 |
| Gentamicin | Gentamicin sulfate 40 mg/mL | Injection, SolutionIntramuscular, Intravenous | REMEDYREPACK INC. | Sep 17, 2026 | 70518-4757 |
| Dextromethorphan hydrobromide and quinidine sulfate | Dextromethorphan hydrobromide 20 mg/1; Quinidine sulfate 10 mg/1 | CapsuleOral | Teva Pharmaceuticals, Inc. | Sep 16, 2026 | 0480-2602 |
| Geodonziprasidone | Ziprasidone 40 mg/1 | CapsuleOral | Viatris Specialty LLC | Sep 16, 2026 | 58151-132 |
| Naproxen | Naproxen 500 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | Sep 16, 2026 | 60760-190 |
| Temozolomide | Temozolomide 100 mg/1 | CapsuleOral | OPKO Pharmaceuticals, LLC | Sep 16, 2026 | 70301-2005 |
| Temozolomide | Temozolomide 140 mg/1 | CapsuleOral | OPKO Pharmaceuticals, LLC | Sep 16, 2026 | 70301-2007 |
| Temozolomide | Temozolomide 180 mg/1 | CapsuleOral | OPKO Pharmaceuticals, LLC | Sep 16, 2026 | 70301-2009 |
| Temozolomide | Temozolomide 250 mg/1 | CapsuleOral | OPKO Pharmaceuticals, LLC | Sep 16, 2026 | 70301-2011 |
| Cyclophosphamide | Cyclophosphamide 25 mg/1 | CapsuleOral | OPKO Pharmaceuticals, LLC | Sep 16, 2026 | 70301-2013 |
| Cyclophosphamide | Cyclophosphamide 50 mg/1 | CapsuleOral | OPKO Pharmaceuticals, LLC | Sep 16, 2026 | 70301-2015 |
| Ofloxacin | Ofloxacin 3 mg/mL | SolutionAuricular (Otic) | REMEDYREPACK INC. | Sep 16, 2026 | 70518-4752 |
| Folic Acid | Folic acid 1 mg/1 | TabletOral | REMEDYREPACK INC. | Sep 16, 2026 | 70518-4756 |
| dicyclomine hydrochloride | Dicyclomine hydrochloride 10 mg/1 | CapsuleOral | Hikma Pharmaceuticals USA Inc. | Sep 15, 2026 | 0054-0883 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 12.5 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | Sep 15, 2026 | 33342-369 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 25 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | Sep 15, 2026 | 33342-370 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 50 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | Sep 15, 2026 | 33342-371 |
| Milnacipran Hydrochloride | Milnacipran hydrochloride 100 mg/1 | TabletOral | Macleods Pharmaceuticals Limited | Sep 15, 2026 | 33342-372 |
| Ibuprofen | Ibuprofen 400 mg/1 | Tablet, Film coatedOral | Ascend Laboratories, LLC | Sep 15, 2026 | 67877-737 |
| Ibuprofen | Ibuprofen 600 mg/1 | Tablet, Film coatedOral | Ascend Laboratories, LLC | Sep 15, 2026 | 67877-738 |
| Ibuprofen | Ibuprofen 800 mg/1 | Tablet, Film coatedOral | Ascend Laboratories, LLC | Sep 15, 2026 | 67877-739 |
| Olmesartan medoxomil and hydrochlorothiazide | Olmesartan medoxomil 40 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | Sep 15, 2026 | 70518-4754 |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/20mL | Injection, SolutionIntravenous | Armas Pharmaceuticals Inc. | Sep 15, 2026 | 72485-515 |
| Carboprost Tromethamine | Carboprost tromethamine 250 ug/mL | Injection, SolutionIntramuscular | Armas Pharmaceuticals Inc. | Sep 15, 2026 | 72485-525 |